N05.5
Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis
Clinical Classification Guidelines
Inclusion Terms
- Unspecified nephritic syndrome with membranoproliferative glomerulonephritis, types 1 and 3, or NOS
Excludes Type 1
- Unspecified nephritic syndrome with C3 glomerulonephritis (N05.A)
- Unspecified nephritic syndrome with C3 glomerulopathy (N05.A)
Medical Intelligence & Overview
Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis is a kidney condition characterized by inflammation and damage to the tiny filtering units within the kidneys called glomeruli. This condition falls under the broader category of nephritic syndromes and involves a specific type of glomerulonephritis known as membranoproliferative glomerulonephritis (MPGN), which includes types 1 and 3. It is termed 'unspecified' because it does not specify a precise subtype of the condition, but it indicates a form where the inflammation affects the entire glomerular structure.
Causes & Symptoms
Clinical Causes: Immune system disorders causing abnormal antibody production Infections such as hepatitis C or hepatitis B Chronic immune diseases like lupus erythematosus Certain genetic predispositions Idiopathic causes, where no clear cause is identified
Key Symptoms: Prolonged or sudden onset of blood in the urine (hematuria) Swelling in the face, hands, feet, or abdomen due to fluid retention High blood pressure Foamy urine caused by excess protein Reduced urine output in advanced cases Fatigue and general feeling of unwellness Nausea or decreased appetite
Diagnostic & Treatment
Diagnosis Path: To diagnose this condition, healthcare providers may perform several tests: - Urinalysis to detect blood and protein in urine - Blood tests to assess kidney function and look for immune activity - Kidney biopsy to examine tissue samples under a microscope, revealing patterns typical of mesangiocapillary glomerulonephritis - Imaging studies if necessary, to evaluate kidney size and structure These diagnostic steps help confirm the presence of inflammation involving the glomeruli and distinguish this condition from other kidney disorders.
Treatment Protocols: While specific treatments depend on the individual case and underlying causes, common approaches include: - Medications to suppress immune responses, such as corticosteroids or immunosuppressants - Blood pressure control with antihypertensive drugs, particularly ACE inhibitors or ARBs - Diuretics to manage swelling and fluid retention - Plasma exchange or plasmapheresis in certain severe cases to remove harmful immune complexes - Monitoring kidney function regularly to assess disease progression It is important for patients to follow their healthcare provider’s recommendations and attend regular check-ups for optimal management.
Clinical Advice & FAQs
Billing Guidance
Is N05.5 a billable ICD-10 code?
Yes, N05.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N05.5?
Clinical documentation must specify the nature of Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference